Synchrotron nano-FTIR spectroscopy for probing anticancer drugs at subcellular scale

Sci Rep. 2024 Jul 26;14(1):17166. doi: 10.1038/s41598-024-67386-y.

Abstract

The cellular response to cisplatin was assessed in human osteosarcoma cells, using synchrotron-based (SR) Fourier Transform InfraRed nanospectroscopy (nano-FTIR) at the MIRIAM beamline B22 of Diamond Light Source (UK). This label-free mapping method delivered simultaneous morphological and biochemical information on a subcellular level (i.e. 100 s nanometer or better). Based on specific spectral biomarkers, the main biochemical constituents affected by the drug were identified at distinct locations within the cell´s inner body. Cisplatin was shown to have a noteworthy effect on proteins, mostly within the cytoplasm. A clear drug impact on cellular lipids was also observed. Within current literature on s-SNOM, this nanospectroscopy work represents a first successful application in life sciences providing full fingerprint nano-FTIR spectra across intact human cancer cells.

Keywords: Cisplatin; Nano-Fourier Transform Infrared (nano-FTIR); Nanospectroscopy; Osteosarcoma; Scattering-Scanning Near field Optical Microscopy (s-SNOM); Synchrotron Radiation (SR).

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Cell Line, Tumor
  • Cisplatin* / pharmacology
  • Humans
  • Osteosarcoma / drug therapy
  • Osteosarcoma / metabolism
  • Osteosarcoma / pathology
  • Spectroscopy, Fourier Transform Infrared / methods
  • Synchrotrons*

Substances

  • Antineoplastic Agents
  • Cisplatin